Aberdeen Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $174M | Buy |
2,766,280
+121,968
| +5% | +$9.76M | 0.28% | 67 |
|
|
2025
Q4 | $252M | Sell |
2,644,312
-632
| -0% | -$62K | 0.39% | 34 |
|
|
2025
Q3 | $258M | Buy |
2,644,944
+52,490
| +2% | +$5.44M | 0.41% | 34 |
|
|
2025
Q2 | $276M | Sell |
2,592,454
-242,523
| -9% | -$24.5M | 0.47% | 30 |
|
|
2025
Q1 | $284M | Buy |
2,834,977
+213,753
| +8% | +$21.5M | 0.55% | 23 |
|
|
2024
Q4 | $234M | Sell |
2,621,224
-317,252
| -11% | -$27.9M | 0.44% | 40 |
|
|
2024
Q3 | $244M | Sell |
2,938,476
-269,470
| -8% | -$21.2M | 0.45% | 41 |
|
|
2024
Q2 | $247M | Sell |
3,207,946
-269,577
| -8% | -$19.7M | 0.47% | 37 |
|
|
2024
Q1 | $238M | Sell |
3,477,523
-132,311
| -4% | -$8.51M | 0.47% | 39 |
|
|
2023
Q4 | $209M | Sell |
3,609,834
-3,105,060
| -46% | -$166M | 0.45% | 40 |
|
|
2023
Q3 | $355M | Sell |
6,714,894
-1,060,327
| -14% | -$55.6M | 0.9% | 15 |
|
|
2023
Q2 | $421M | Sell |
7,775,221
-84,684
| -1% | -$4.42M | 0.98% | 15 |
|
|
2023
Q1 | $393M | Buy |
7,859,905
+250,972
| +3% | +$11.8M | 0.98% | 16 |
|
|
2022
Q4 | $352M | Sell |
7,608,933
-362,182
| -5% | -$15.7M | 0.96% | 16 |
|
|
2022
Q3 | $309M | Sell |
7,971,115
-412,104
| -5% | -$16.5M | 0.92% | 16 |
|
|
2022
Q2 | $315M | Sell |
8,383,219
-308,985
| -4% | -$12.6M | 0.99% | 10 |
|
|
2022
Q1 | $391M | Sell |
8,692,204
-355,817
| -4% | -$15.4M | 1% | 11 |
|
|
2021
Q4 | $384M | Buy |
9,048,021
+137,304
| +2% | +$5.77M | 0.84% | 16 |
|
|
2021
Q3 | $392M | Sell |
8,910,717
-533,988
| -6% | -$23.6M | 0.88% | 15 |
|
|
2021
Q2 | $404M | Sell |
9,444,705
-327,487
| -3% | -$13.8M | 0.88% | 19 |
|
|
2021
Q1 | $378M | Buy |
9,772,192
+523,693
| +6% | +$19.8M | 0.86% | 21 |
|
|
2020
Q4 | $332M | Sell |
9,248,499
-569,460
| -6% | -$20.5M | 0.81% | 22 |
|
|
2020
Q3 | $375M | Buy |
9,817,959
+117,770
| +1% | +$4.54M | 1% | 14 |
|
|
2020
Q2 | $341M | Buy |
9,700,189
+650,732
| +7% | +$23.4M | 0.92% | 21 |
|
|
2020
Q1 | $295M | Buy |
9,049,457
+1,177,393
| +15% | +$46M | 0.94% | 23 |
|
|
2019
Q4 | $356M | Buy |
7,872,064
+168,087
| +2% | +$7.03M | 0.86% | 25 |
|
|
2019
Q3 | $314M | Sell |
7,703,977
-318,056
| -4% | -$13.5M | 0.78% | 30 |
|
|
2019
Q2 | $345M | Buy |
8,022,033
+300,291
| +4% | +$11.6M | 0.77% | 28 |
|
|
2019
Q1 | $296M | Sell |
7,721,742
-1,601,460
| -17% | -$61.2M | 0.64% | 39 |
|
|
2018
Q4 | $321M | Sell |
9,323,202
-2,773,540
| -23% | -$101M | 0.76% | 30 |
|
|
2018
Q3 | $466M | Sell |
12,096,742
-1,901,611
| -14% | -$66.4M | 0.87% | 23 |
|
|
2018
Q2 | $458M | Buy |
13,998,353
+178,939
| +1% | +$5.4M | 0.88% | 24 |
|
|
2018
Q1 | $378M | Buy |
13,819,414
+1,239,680
| +10% | +$33.7M | 0.75% | 32 |
|
|
2017
Q4 | $312M | Sell |
12,579,734
-102,367
| -0.8% | -$2.82M | 0.6% | 46 |
|
|
2017
Q3 | $370M | Buy |
+12,682,101
| New | +$350M | 0.67% | 38 |
|
Other funds holding BSX
VCM
VPM
Aberdeen Group's BSX Position: Q1 2026 in Review
Aberdeen Group increased its Boston Scientific (BSX) stake by 4.6% in Q1 2026, buying an estimated $9.76M and bringing the position to 2,766,280 shares worth $174M. The position accounts for 0.28% of the portfolio, ranked #67.
Aberdeen Group first reported a position in BSX in Q3 2017 and has held it in 35 quarters since. The position peaked at $466M in Q3 2018. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Aberdeen Group held 2,766,280 shares of Boston Scientific worth $174M as of Q1 2026.
- Aberdeen Group bought 121,968 Boston Scientific shares in Q1 2026, an estimated $9.76M.
- Boston Scientific made up 0.28% of Aberdeen Group's portfolio in Q1 2026, its #67 holding.
- Aberdeen Group first reported a position in Boston Scientific in Q3 2017 and has held it in 35 quarters since.
- Aberdeen Group's Boston Scientific position peaked at $466M in Q3 2018.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.